Clinical Trials Browser

Phase 1 × INDUSTRY × tipifarnib × Clear all

NCT04865159 2023-09-21

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT05693090 2023-03-06

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

Phase 1 Withdrawn

NSCLC